NFKB1
NFKB1 (nuclear factor kappa B subunit 1) encodes the NF-kappa-B p105 subunit, a precursor that is processed to the DNA-binding p50 subunit of the NF-kappa-B transcription factor. It is also known as KBF1, p105, p50 and NF-kB1. Browse Assay Genie's current range of NFKB1 research reagents below, or read on for the biology behind the target.
NFKB1 encodes a protein with two distinct roles. The full-length 105 kD form acts as a Rel protein-specific transcription inhibitor, while cotranslational processing by the 26S proteasome yields a 50 kD protein, the DNA-binding subunit of the NF-kappa-B (NFKB) complex. The processed form constitutes the active protein, which associates with RELA/p65 to form the NF-kappa-B p65-p50 transcription factor. Together with RELA/p65, it binds the kappa-B consensus sequence 5'-GGRNNYYCC-3' in the enhancer region of genes involved in immune response and acute phase reactions.
NFKB is a transcription regulator activated by diverse intra- and extra-cellular stimuli, including cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Once activated, it translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. UniProt records the protein in both the cytoplasm and the nucleus, consistent with this shuttling. NFKB is described as a critical regulator of the immediate-early response to viral infection. Alternative splicing of the NFKB1 gene gives multiple transcript variants encoding different isoforms, at least one of which is proteolytically processed.
HGNC places NFKB1 in the ankyrin repeat domain containing, NF-kappa B complex subunits, IPT domain containing and NFKB inhibitor family gene groups. Its previous name was nuclear factor of kappa light polypeptide gene enhancer in B-cells 1. Inappropriate NFKB activation has been associated with a number of inflammatory diseases, whereas persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. Orthologous genes are named Nfkb1 in both mouse and rat.
Inappropriate NFKB activation has been associated with a number of inflammatory diseases, making NFKB1 a frequent subject of inflammatory signalling studies.
NFKB is a critical regulator of the immediate-early response to viral infection, and NFKB1 processing is relevant to how that response is controlled.
Persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth, linking NFKB1 to immune and growth studies.
The p50 subunit pairs with RELA/p65 to bind kappa-B sites in enhancers of immune response and acute phase genes.
NFKB1 encodes a 105 kD precursor that acts as a Rel protein-specific transcription inhibitor. Proteasomal processing yields the 50 kD subunit, which pairs with RELA/p65 to bind kappa-B sites in enhancers of genes involved in immune response and acute phase reactions.
NFKB1 is also called KBF1, NF-kB1, NFKB-p50 and NF-kappaB. The 105 kD full-length protein is p105, and the processed DNA-binding subunit is p50. Its earlier HGNC name was nuclear factor of kappa light polypeptide gene enhancer in B-cells 1. Alternative splicing produces several isoforms.
Mouse and rat both have an orthologous gene named Nfkb1. Inappropriate NFKB activation has been associated with a number of inflammatory diseases, while persistent inhibition leads to inappropriate immune cell development or delayed cell growth. Check the datasheet of any product for its validated reactivity.
Other NF-kappa-B subunits, the p65 partner and NFKB inhibitor family members with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P19838; product specifications from Assay Genie datasheets.